Respiri Limited (RSH, formerly iSonea Limited) is an international e-Health SaaS company that has revolutionized respiratory health management. With a primary focus on supporting the US remote patient monitoring market, Respiri's world-first technology goes beyond traditional monitoring. It detects wheeze, a typical symptom of Asthma, COPD and other respiratory diseases, providing an objective measure of airway limitation. This crucial data empowers healthcare providers to make more informed decisions about treatment plans and improve patient outcomes.